Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionRock Point Advisors, LLC
Latest Disclosed Ownership1,786,681 shares
Latest Disclosed Value $ 4,073,633
Rock Point Advisors, LLC reports 50.12% increase in ownership of 9EH / Evolent Health, Inc.

On May 14, 2026 - Rock Point Advisors, LLC filed a 13F-HR form disclosing ownership of 1,786,681 shares of Evolent Health, Inc. (DE:9EH) valued at $3,376,827 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 1,190,156 shares of Evolent Health, Inc.. This represents a change in shares of 50.12% during the quarter. The current value of the position is $6,038,982 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Evolent Health CL A 30050B101 1,786,681 596,525 50.12 4,074 -14.43 1.1022
2026-02-04 2025-12-31 13F Evolent Health CL A 30050B101 1,190,156 211,707 21.64 4,761 -42.49 1.1917
2025-11-12 2025-09-30 13F Evolent Health CL A 30050B101 978,449 128,489 15.12 8,278 -13.51 2.1936
2025-08-14 2025-06-30 13F Evolent Health CL A 30050B101 849,960 25,425 3.08 9,571 22.57 2.6998
2025-04-30 2025-03-31 13F Evolent Health CL A 30050B101 824,535 225,396 37.62 7,808 15.85 2.4085
2025-02-13 2024-12-31 13F Evolent Health CL A 30050B101 599,139 133,357 28.63 6,740 -48.83 1.9648
2024-11-13 2024-09-30 13F Evolent Health CL A 30050B101 465,782 -26,605 -5.40 13,172 39.92 3.5965
2024-08-08 2024-06-30 13F Evolent Health CL A 30050B101 492,387 140,780 40.04 9,414 -18.35 2.8230
2024-05-10 2024-03-31 13F Evolent Health CL A 30050B101 351,607 -31,904 -8.32 11,529 -8.98 3.4246
2024-02-08 2023-12-31 13F Evolent Health CL A 30050B101 383,511 8,240 2.20 12,667 23.97 3.8417
2023-11-09 2023-09-30 13F Evolent Health CL A 30050B101 375,271 44,823 13.56 10,219 2.06 3.5365
2023-08-10 2023-06-30 13F Evolent Health CL A 30050B101 330,448 -21,359 -6.07 10,013 90,918.18 3.2877
2023-05-10 2023-03-31 13F Evolent Health CL A 30050B101 351,807 -3,544 -1.00 11 22.22 3.8799
2023-02-09 2022-12-31 13F Evolent Health CL A 30050B101 355,351 30,510 9.39 10 -99.92 3.4538
2022-11-10 2022-09-30 13F Evolent Health CL A 30050B101 324,841 -8,800 -2.64 11,672 13.92 4.3386
2022-08-10 2022-06-30 13F Evolent Health CL A 30050B101 333,641 -57,973 -14.80 10,246 -19.00 3.4991
2022-05-10 2022-03-31 13F Evolent Health CL A 30050B101 391,614 2,535 0.65 12,649 17.49 3.7706
2022-02-09 2021-12-31 13F Evolent Health CL A 30050B101 389,079 -26,011 -6.27 10,766 -16.34 3.0312
2021-11-05 2021-09-30 13F Evolent Health CL A 30050B101 415,090 -69,875 -14.41 12,868 25.64 3.7686
2021-08-05 2021-06-30 13F Evolent Health CL A 30050B101 484,965 55 0.01 10,242 4.56 2.9501
2021-05-12 2021-03-31 13F Evolent Health CL A 30050B101 484,910 -46,795 -8.80 9,795 14.92 3.0520
2021-02-08 2020-12-31 13F Evolent Health CL A 30050B101 531,705 -29,789 -5.31 8,523 22.32 2.9296
2020-11-10 2020-09-30 13F Evolent Health CL A 30050B101 561,494 -106,699 -15.97 6,968 46.45 3.0850
2020-08-12 2020-06-30 13F Evolent Health CL A 30050B101 668,193 -79,120 -10.59 4,758 17.25 2.2170
2020-05-07 2020-03-31 13F Evolent Health CL A 30050B101 747,313 214,815 40.34 4,058 -15.79 2.4061
2020-02-06 2019-12-31 13F Evolent Health CL A 30050B101 532,498 -93,217 -14.90 4,819 7.11 1.9570
2019-11-08 2019-09-30 13F Evolent Health CL A 30050B101 625,715 191,230 44.01 4,499 30.25 2.0317
2019-08-12 2019-06-30 13F Evolent Health CL A 30050B101 434,485 191,455 78.78 3,454 12.99 1.5714
2019-05-08 2019-03-31 13F Evolent Health CL A 30050B101 243,030 243,030 3,057 1.4383
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.